| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.056 | 0.2 |